36、 Meropol NJ.Oral fluoropyrimidines in the treatment of colorectal cancer.Eur J Cancer，1998，34:1509-1513.
37、Twelve C，Wong A， Nowacki MP，et al.Capecitabine as adjuvant treatment for
Starge III colon cancer.N Engl J Med，2005，352:2696-2704.
38、 De Gramont A， Bosset J-F， Milan CH， et al.Randomized trial compar-ing monthly
Low-dose leucoverin and fluorouracil bulos with bimonthly high-dose leucoverin and fluorouracil bolus plus continuous infusion for advanved colorectal cancer:A French Intergroup Study.J Clin Oncol，1997，15:808-815.
39、Entremont TS and Hallter DG.Recent advances in chemotherapy for colorectal cancer.Oncology，2003，6:151-161.
40、 De Gramont A，Boni C，Navarro M, et al.Oxaliplatin/5-Fu/ LV in the adjuvant treatment of stage IIand III colon cancer， Efficancy result with a median follow-up of 4 years.4lth ASCO Annal Meeting Proceeding.2005，2465:3501.
41、 Schuster L.针对结直肠癌肝转移的最新化疗方案.肿瘤时讯.2005.12:13.
42、 Braun MS，A dab F，Bradley C， et al.Modified de Gramont with oxalipatin in the first- line treatment of advanced colorectal cancer.Br J Cancer，2003， 89:1155- 1158.
43、Maindraul t-Goebel F， de Gramont A，Louvet C， et al.High- dose intensity Oxalipatin added to the simplified bimonthly leueovorin and 5-fluorouracil regimen as second- line therapy for metastatic colorectal cancer(FOLFOX7). Eur J Cancer.2001，37:1000一1005.
44、 William HI， ROW E PM.Camptothecin new enthusiasm for old drug.Lancet，1995，347:892.
45、徐工学，李志霞，陈佛来.结直肠癌术前区域化疗.国外医学外科学分册，2000，27:347-349.
45、朱培谦，谢敏，曹家庆.术前选择性区域动脉插管灌注化疗在直肠癌治疗中的应用.实用癌症杂志，2001，16:639
46、黄鸿遮，周小牛，黄金华.术前动脉灌注化疗治疗疗效的分析.中国实用外科杂志，1998，18:287.
47、刘勇敢，藏军现，许震，等.直肠癌根治术后行多动脉联合化疗对预防复发和转移的价值.中国肿瘤临床与康复， 2001，8:49.
48、Liver In fusion Meta-analysis Group.Portal vein chemotherapy for colorectal cancer meta- analysis of 4000 patients in studies.J Natl Cancer Inst，1997，89:497-505.
49、FunamiY，TokumoH M，YuchiH, et al.Prognostic value of peritoneal lavage eytology and chemotherapy daring surgery for advanced gastric cancer.Int Surg， 1999，84:220-224.
50、陆耀良.腹腔化疗在结直肠癌中的应用.国外医学肿瘤学分册，1998，25:112-114.
51、张守亮，王茂龙.结直肠癌淋巴靶向化疗的研究进展.国外医学肿瘤学分册，2003，30:381-384.
52、Chan L，Cunningham D:Adjuvant chemotherapy in colon cancer:State of the art .ASCO Educational book，2002，228-239.
53、Sargent DJ，Goldberg RM， Ja Cobson SD， et al.A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.N Engl J Med，200l，345:1091一1097.
54、Rangier P:Palliative and adjuvant chemotherapy in colorectal cancer.ECCO Educational Book，200l， 185-202.
55、 Rubin P:Clinicol Oneology.W.B.Saunders Company:Philadelphia 8th edition，2001，729-730.
56、 De Gomont A，Banzi M， Navarro M et al:Oxaliplatin/5- FU/LV in adjuvant colon cancer:Safety result of the international randomized MOSAIO trial.Proceeding of ASCO，2002，12(Abstr525).
57、 De Gramont A，Banzi M，Navarro M et al:OxaliPlatin/5- FU/LV in adjuvant colon cancer:Results of the international randomized MOSAIO trial.Proeeeding of ASCO，2003，Abstrl015.
58、Pazdur R，Coia LR， Hoskins WJ，et al:Cancer Management:A multidisciplinary approach.Oncology New Intemational:New York.Seventh edition，2003，323:352.
59、 ROW E PM.Camptothecin new enthusiasm for old drug.Lancet，1995，347:892.
60、 ROTH ENBERH ML,LCKARDT JR，KUHN JG，et al.Phase II trail of irinotecan in patients with progressive of rapidly recurrent colorectal cancer.J Clin O ncol， 1996，14:1128- 1135.
61、BODLEY A，LIU LF，ISRAELM，et al.DNA topoisonerase II mediated，信捷职称论文写作发表网，and daunoru- bicin of doxorubicin corgeners with DNA.Cancer Res，1989，29:5969-5978.
62、潘启超.抗癌新药-拓朴异构酶I抑制剂.中国新
